UNITEDHEALTH GROUP INC (UNH)

US91324P1021 - Common Stock

510.1  +6.37 (+1.26%)

After market: 510.1 0 (0%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to UNH. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 584.93. This target is 14.67% above the current price.
UNH was analyzed by 31 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about UNH.
In the previous month the buy percentage consensus was at a similar level.
UNH was analyzed by 31 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 510.10525.20579.87584.93682.50 - 2.96% 13.68% 14.67% 33.80%
Up and Down Grades
Date Firm Action Rating
2023-09-14 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-09-06 HSBC Initiate Hold
2023-08-11 Stephens & Co. Reiterate Overweight -> Overweight
2023-07-19 UBS Maintains Neutral -> Neutral
2023-07-18 Bernstein Upgrade Market Perform -> Outperform
2023-07-17 Deutsche Bank Maintains Buy -> Buy
2023-07-17 Oppenheimer Reiterate Outperform -> Outperform
2023-07-17 RBC Capital Maintains Outperform -> Outperform
2023-07-14 Morgan Stanley Reiterate Overweight -> Overweight
2023-07-13 UBS Maintains Neutral -> Neutral
2023-07-13 Wells Fargo Maintains Overweight -> Overweight
2023-07-11 Mizuho Maintains Buy -> Buy
2023-07-07 JP Morgan Maintains Overweight -> Overweight
2023-06-27 Truist Securities Reiterate Buy -> Buy
2023-06-16 Oppenheimer Reiterate Outperform -> Outperform
2023-06-14 SVB Securities Maintains Outperform
2023-06-14 Mizuho Reiterate Buy -> Buy
2023-06-14 RBC Capital Reiterate Outperform -> Outperform
2023-06-14 Truist Securities Maintains Buy
2023-05-30 JP Morgan Maintains Overweight -> Overweight
2023-05-26 Piper Sandler Initiate Overweight
2023-04-21 Cantor Fitzgerald Initiate Overweight
2023-04-17 TD Cowen Maintains Outperform
2023-04-17 Oppenheimer Reiterate Outperform
2023-04-17 RBC Capital Reiterate Outperform
2023-04-17 Loop Capital Maintains Buy
2023-04-17 Raymond James Maintains Strong Buy
2023-04-14 Raymond James Maintains Strong Buy
2023-04-05 Raymond James Upgrade Outperform -> Strong Buy
2023-02-28 Stephens & Co. Reiterate Overweight